Michael Golinkoff
Showing 1–3 of 3 transcripts.
- Milken Institute58 min
Poised to Break the Bank: Paying for Chronic Disease
Allison, Anand, Tom, Nancy, Paul Davis, Eric, Michael Golinkoff, John Rother, Megan Golden, Jess Leifer, Stephanie Cousins
A multi-sector consensus addresses the $2.4 trillion annual burden of chronic U.S. diseases by implementing interventions like Geisinger's Food Pharmacy, which reduces healthcare costs by aligning patient acuity with intensive lifestyle support. While capitated payment models and digital innovations such as Omada Health improve scalability and outcomes, structural barriers including payer misalignment and low screening rates for prediabetes necessitate policy shifts toward sugar taxes and multi-payer funding. Concurrently, the medical landscape is pivoting from opioid reliance to holistic pain management and gene therapies, with academic institutions like Kaiser Permanente adapting curricula to prioritize prevention and address the mental health needs of 74% of employees.
- Milken Institute1h 0m
The Business Case for Addressing Social Determinants of Health
Joanne Kenen, Georges Benjamin, Thomas Moriarty, Ashley Perry, Lauren Shweder Biel, Emily Yu, Joanne Cannon, Lauren Schwader-Beal, Katherine Connelly, Michael Golinkoff
Moderated by Joanne Cannon, a panel of public health leaders and corporate strategists redefined the conversation around Social Determinants of Health by prioritizing the business case for intervention over traditional philanthropy. Speakers detailed scalable models such as DC Greens' produce prescription program and CVS's integrated health hubs, which leverage data-driven insights to prove cost savings through medication compliance and reduced emergency room visits. The group concluded that sustainable growth depends on transitioning funding from grants to payer reimbursement within value-based care systems, leveraging political and corporate influence to address root causes like housing instability.
- Milken Institute1h 1m
Opioid Addiction: A Crisis Fueled by Stigma
Robert Redfield, Sarah Carlin-Smith, Dr. Kelly Clark, Gary Mendel, Dr. Andrei Ostrovsky, Jerome Adams, Ronnie Solomon, Michael Golinkoff
A collaborative panel led by Surgeon General officials and researchers from Shatterproof and McKinsey identifies stigma as the primary barrier in the opioid crisis, highlighting how it drives public misunderstanding, provider bias, and critical gaps in Medicaid and federal funding. The group outlines a strategic shift toward humanizing recovery narratives, integrating addiction care into chronic disease management frameworks, and utilizing settlement funds for evidence-based programs to reduce overdose mortality by 50%. By advocating for the removal of restrictive privacy laws like 42 CFR Part 2 and the elimination of the X-waiver, the initiative seeks to dismantle systemic prejudices that currently prevent 60% of treatment facilities from offering FDA-approved medications.